ClinicalTrials.gg
Not yet recruitingNCT07906236Updated Nov 5, 2026

Esthetic Impact of Different Minimally Invasive Approaches on Hypomineralized Permanent Anterior Teeth

An interventional study of ICON® resin infiltration and Opalustre® enamel microabrasion in Enamel Hypomineralization, Dental, sponsored by Shaimaa Abdelrahman. Not yet recruiting at 1 site in Egypt. Open to participants aged 7 Years to 12 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-11-05.

Sponsored by Shaimaa Abdelrahman · Not applicable, Interventional, and Treatment

Updated Nov 5, 2026Start date movedPrimary completion moved+2 moreGo to Updates ↓
Phase
Not applicable
Study type
Interventional
Enrollment
69
Allocation
Randomized
Ages
7 Years to 12 Years
Sex
All
01

Study summary

The aim of the study is to determine the effectiveness of minimally invasive treatments in reducing the visible enamel opacities on permanent anterior teeth in children aged from seven to twelve years with hypomineralized lesions.

A secondary purpose is to evaluate patient satisfaction and the psychosocial impact of the treatment on the esthetic perception of the treated children.

The results of all the research papers about treating enamel discoloration caused by hypomineralization with the ICON system can be accepted as satisfactory. However, not all cases achieved the full aesthetic aim.

Microabrasion is an acid abrasive removal and not the dissolution of enamel stain. It is as a treatment modality for enamel opacities like brown, orange, or yellow enamel spots; and fluorotic white streaks. Esthetic results could be reached when microabrasion followed by a remineralizing agent such as C PP-ACFP.

Null hypothesis, there is no difference between microabrasion followed by a remineralizing agent and resin infiltration treatment regarding clinical effectiveness \& patient satisfaction.

Read the detailed description

Outcomes:

Primary outcome Color enhancement using Clinical photographs (Bhandari, et al., 2019). Secondary outcomes

  • Patient satisfaction will be evaluated using Numerical scale (NS), (Figure 1). The participant marked the number that represented their self-assessed satisfaction (Rocha et al., 2020) as shown in Appenxix II.
  • Psychosocial impact of the treatment on the esthetic perception of the treated children will be evaluated using The Psychosocial Impact of Dental Aesthetics Questionnaire (PIDAQ) (Klages et al., 2006). Appendix III.
  • Reducing teeth hypersensitivity will be evaluated using The Schiff Cold Air Sensitivity Scale (SCASS) (Schiff et al., 1994).
  • Adverse and undesirable side effects experienced by the respondents: a) pain in teeth and gums will be evaluated using The Wong-Baker FACES® Pain Rating Scale (Wong et al., 1988). Appendix IV.
  • b) bitter taste will be evaluated by asking the child right after treatment. (Athayde et al., 2022).
  • Follow up:

Follow up after 1 day for adverse and undesirable side effects, 1week \& 6 months.

Randomization:

The participants will be randomly assigned to one of the three experimental groups the interventions and control groups using simple randomization with a 1:1 allocation ratio.

Masking/blinding:

Neither the operator nor the patients could be blinded due to the nature of the study but the outcome assessor and statistician will be blinded.

02

Conditions studied

  • Enamel Hypomineralization, Dental

Keywords

  • Hypomineralized enamel; microabrasion
03

In context

Dental Enamel Hypomineralization

20 studies on the registry are indexed under Dental Enamel Hypomineralization; 6 are open to participants now.

This study's planned enrollment of 69 is above the median of 45 across 15 interventional studies indexed under Dental Enamel Hypomineralization.

Browse Dental Enamel Hypomineralization studies →

Lead sponsor

This is the only study on the registry with Shaimaa Abdelrahman as lead sponsor.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
7 Years to 12 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • ▪ Participants free from any systemic disease aged from 7 years to 12 years

    • Anterior permanent teeth with Degree 1(mild) hypomineralization (according to the Wetzel and Reckel scale) (as shown in Appenxix I).
    • Enamel opacities, (White, creamy or yellow to brownish colour), without enamel breakdown
    • Caries-free teeth.
    • Sensitivity to external stimuli e.g., air/water but not brushing.

Exclusion criteria

Exclusion Criteria:

  • ▪ Dental caries and filling,

    • Loss of the enamel or dentin structure,
    • Clinical symptoms of irreversible pulpitis such as spontaneous pain or persisting pain,
    • Previous use of bleaching agent.
    • Dental anomaly on anterior teeth,
    • Periodontal diseases,
    • Undergoing orthodontic treatment,
    • Cognitive and behavioral conditions.
    • Patients with milk protein or hydroxybenzoates allergies.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
69 participants (estimated)

Study arms

  • Active comparator
    Control group ICON® resin infiltration

    Resin infiltration treatment (Icon®) for Hypomineralized anterior permanent teeth in children

    Other: ICON® resin infiltration

  • Experimental
    Intervention group 1

    Opalustre® Enamel Microabrasion Slurry

    Other: Opalustre® enamel microabrasion

  • Experimental
    Intervention group 2

    Antivet® enamel micro-abrasion

    Other: Antivet® enamel micro-abrasion

Interventions

  • OtherICON® resin infiltration

    * Applying a 15% hydrochloric acid gel (ICON-Etch; DMG; Hamburg, Germany®) for 120 s using the Icon® etch syringe included in the set, * followed by a thorough washing of the etchant for 30 s. and Dring the tooth using an air spray, * Once the enamel surface appeared chalky, Ethanol lesion desiccation (ICON-Dry; DMG®) will be performed for 30 s, * followed by drying using an air spray. * Using the Icon® infiltrant syringe Infiltration with a sufficient amount resin (ICON-Infiltrate; DMG®) of the lesion surface by massaging the tip of the syringe on the lesion in circular movements for 3 min. * Before drying, clean the remaining material and excess removal by Gauze or cotton swab and dental floss. * Light curing for 40 s with a light-cure device, * Then another round of infiltration will take place * One minute was provided for the material to infiltrate the pores, after which it was polymerized for 40 s.

  • OtherOpalustre® enamel microabrasion

    * Isolation is extremely important because of the hydrochloric acid. Patients and clinician should both wear protective eyewear. * Isolate teeth to be treated and one tooth posterior on each side using rubber dam. * For additional protection, apply a bead of rubber dam sealer or light-cured resin barrier at the gingival margin beneath the dam. NOTE: For hypo-mineralization greater than 0.1-0.3mm use a fine-grit water-cooled tapered diamond bur, lightly sweep over the stained area for 5-10 seconds prior to applying Opalustre. * Apply approximately 1.0mm thick layer over the discolored area from Opalustre syringe with the White Mac tip. * Using a rubber prophy cup at a slow RPM (approximately 500 RPM), apply medium to heavy pressure for 60 seconds at a time. * Suction the paste from the teeth first, then rinse, evaluate and repeat as necessary. * Aesthetic improvement should be visualized on the wet surfaces. * After final rinse, remove rubber dam, and sealer from the teeth. Rinse

  • OtherAntivet® enamel micro-abrasion

    * The Antivet® abrasive solution (MDC DENTAL, Zapopan Jalisco, México) containing 21% hydrofluoric acid will be placed on the buccal surface with a cotton swab. * When the swab became pigmented, it will change to another clean swab with the abrasive solution. * The procedure would be repeated for 10 min. * When the process is finished, the excess solution will be cleaned using cotton, and calcium hydroxide as a neutralizing solution would be placed for 1 min with a micro brush. * In the end, rinsing with water for 30 s. * Apply MI varnish to the enamel.

06

What researchers measure

Primary outcomes

  1. Color enhancement measured by Clinical photographs

    Clinical photographs will be taken with a digital camera macro lens, and flash. With the patient and digital camera at the same vertical plane and dental clinic illuminated evenly. The photographs will be taken in baseline, during the application time of the test or control. For standardizing the photographic conditions, the camera will be placed at the equidistance from the tooth. To prevent the change of refractive index by moisture, 30 s of drying of the lesion will be done.

    Time frame: 6 months

Secondary outcomes

  1. Patient satisfaction measured by Visual analogue scale

    The patient is asked to draw a line perpendicular to the VAS at their perceived pain-intensity level, no discomfort (score 0), mild discomfort (score 1-3), moderate (score 4-6) and very severe (7-9) or worst discomfort (score 10).

    Time frame: 6 months

  2. Reducing teeth hypersensitivity measured by The Schiff Cold Air Sensitivity Scale (SCASS)

    It is a behavioral scale because it is based on observed behavior in response to a stimulus beyond a certain threshold. The dentist (or another assessor present) rates the response of the patient to the stimulus as 0 for no response to air stimulus, 1. for response to air stimulus but no request for discontinuation of the stimulus, 2. for response to air stimulus and requests discontinuation or moves from the stimulus\& 3. for response to air stimulus, considers stimulus to be painful, and requests discontinuation'

    Time frame: 6 months

07

Study locations

1 site
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

2 registry updates since Sep 25, 2026
Start date
Oct 1, 2026→Jan 1, 2027
Nov 5, 2026
Primary completion
Apr 1, 2027→Jun 1, 2027
Nov 5, 2026
Study completion
Jun 1, 2027→Sep 1, 2027
Nov 5, 2026
Registered
First appeared on the registry
Oct 30, 2026
Show all 2 updates
  1. Nov 5, 2026
    Start date Oct 1, 2026→Jan 1, 2027
    Primary completion Apr 1, 2027→Jun 1, 2027
    Study completion Jun 1, 2027→Sep 1, 2027
  2. Oct 30, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07906236
Lead sponsor
Shaimaa Abdelrahman
Responsible party
Shaimaa Abdelrahman (Pediatric Dentist at Ain Shams General Hospital (Ministry of Health and Population), Cairo University) — Sponsor-investigator
First posted
Oct 30, 2026
Start date
Jan 1, 2027 (estimated)
Primary completion
Jun 1, 2027 (estimated)
Completion
Sep 1, 2027 (estimated)
Last update
Nov 5, 2026

Study contacts

Shaimaa AM Awad, Mcs
Contact
shaimaa.awad@dentistry.cu.edu.eg
01027557531
Aliaa AM Awad
Contact
shaimaa.awad@dentistry.cu.edu.eg
01062811856
Shaimaa AM Awad, Mcs
principal investigator · Cairo Uviversity

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Sep 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion